Log in to save to my catalogue

PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis

PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11290976

PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis

About this item

Full title

PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2024-08, Vol.134 (15), p.1-20

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Proliferative glomerulonephritis is a severe condition often leading to kidney failure. There is a significant lack of effective treatment for these disorders. Here, following the identification of a somatic PIK3CA gain-of-function mutation in podocytes of a patient, we demonstrate using multiple genetically engineered mouse models, single-cell RNA...

Alternative Titles

Full title

PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11290976

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11290976

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI176402

How to access this item